Table 2 Adherence to treatment for the 11 children who completed the study
From: A pilot feasibility study of gabapentin for managing pain in children with dystonic cerebral palsy
Days | % treatment period | |
|---|---|---|
Mean (SD) | Mean (SD) | |
Total treatment period length in days | 84 | 100% |
Total days in which doses were taken (either according to protocol dosage or following adjustment by clinician or not specified) | 56.3 (38.1) | 67.0% (45.4%) |
According to protocol | 33.6 (32.4) | 40.0% (38.6%) |
Following adjustment by clinician | 12.0 (15.7) | 14.3% (18.7%) |
Dosage not specified | 10.6 (19.7) | 12.7% (23.5%) |
Total days in which doses were missed (or dose not reported) | 27.7 (38.1) | 33.0% (45.4%) |